mirvetuximab
immunogen
['mirasol', 'ovarian']
sunday, 7:30am: such an outstanding news at #asco23 : mirasol: 1st phase iii trial to demonstrate os improvements in platinum-resistant #ovariancancer (proc)
..hopefully just the beginning of a new practice-changing era for this so hard-to-treat population! 
PostDoctoral Fellow at @NCICCR_WMB NIH/NCI, Bethesda, MD, U.S. | OB/GYN Resident at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy #gynonc